The role of host genetics in susceptibility to influenza: A systematic review

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Horby, Peter ^a   Nguyen, Nhu Y ^a   Dunstan, Sarah J ^a   Baillie, J Kenneth ^b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; MYXOVIRUS RESISTANCE PROTEINS;

BRAIN DISEASE; DISEASE MODEL; ETHNICITY; GENE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETICS; HERITABILITY; HOST GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MX1 GENE; MX2 GENE; MXA GENE; NONHUMAN; QUANTITATIVE TRAIT LOCUS; REVIEW; SYSTEMATIC REVIEW; VIRUS STRAIN; ANIMAL; AVIAN INFLUENZA; BIRD; BLOOD GROUP ABO SYSTEM; FAMILY; GENETIC PREDISPOSITION; HOST PATHOGEN INTERACTION; MOUSE; MOUSE STRAIN; SPECIES DIFFERENCE;

AVIAN INFLUENZA VIRUS; PROSPERO;

ABO BLOOD-GROUP SYSTEM; ANIMALS; BIRDS; DISEASE MODELS, ANIMAL; FAMILY; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEINS; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE; MICE, INBRED STRAINS; SPECIES SPECIFICITY;

EID: 84858235640     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033180     Document Type: Review

References (98)

1. Sedyaningsih ER, Isfandari S, Setiawaty V, Rifati L, Harun S, et al. (2007) Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis 196: 522-527.
2. Kandun IN, Wibisono H, Sedyaningsih ER, Yusharmen, Hadisoedarsuno W, et al. (2006) Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 355: 2186-2194.
3. Horby P, Sudoyo H, Viprakasit V, Fox A, Thai PQ, et al. (2010) What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect 138: 1550-1558.
4. Aditama TY, Samaan G, Kusriastuti R, Purba WH, Misriyah, et al. (2011) Risk Factors for Cluster Outbreaks of Avian Influenza A H5N1 Infection, Indonesia. Clin Infect Dis 53: 1237-1244.
5. World Health Organization (2010) Summary of human infection with highly pathogenic avian influenza A (H5N1) virus reported to WHO, January 2003-March 2009: cluster-associated cases. Wkly Epidemiol Rec 85: 13-20.
6. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. (2010) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719.
7. World Health Organization (2009) WHO Public Health Research Agenda for Influenza. Geneva.
8. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, et al. (2010) Human host factors required for influenza virus replication. Nature 463: 813-817.
9. Zhang L, Katz JM, Gwinn M, Dowling NF, Khoury MJ, (2009) Systems-based candidate genes for human response to influenza infection. Infect Genet Evol 9: 1148-1157.
10. Lindenmann J, (1962) Resistance of mice to mouse-adapted influenza A virus. Virology 16: 203-204.
11. Staeheli P, Pravtcheva D, Lundin LG, Acklin M, Ruddle F, et al. (1986) Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16. J Virol 58: 967-969.
12. Arnheiter H, Haller O, Lindenmann J, (1976) Pathology of influenza hepatitis in susceptible and genetically resistant mice. Exp Cell Biol 44: 95-107.
13. Haller O, Arnheiter H, Gresser I, Lindenmann J, (1979) Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med 149: 601-612.
14. Haller O, Arnheiter H, Lindenmann J, Gresser I, (1980) Host Gene Influences Sensitivity to Interferon Action Selectivity for Influenza-Virus. Nature 283: 660-662.
15. Arnheiter H, Haller O, Lindenmann J, (1980) Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus. Virology 103: 11-20.
16. Arnheiter H, Haller O, (1983) Mx gene control of interferon action: different kinetics of the antiviral state against influenza virus and vesicular stomatitis virus. J Virol 47: 626-630.
17. Staeheli P, Danielson P, Haller O, Sutcliffe JG, (1986) Transcriptional activation of the mouse Mx gene by type I interferon. Mol Cell Biol 6: 4770-4774.
18. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O, (1988) Influenza Virus-Susceptible Mice Carry Mx-Genes with a Large Deletion or a Nonsense Mutation. Molecular and Cellular Biology 8: 4518-4523.
19. Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E, (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62: 51-61.
20. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, et al. (2007) Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81: 7776-7785.
21. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P, (2007) Protective role of beta interferon in host defense against influenza A virus. J Virol 81: 2025-2030.
22. Haller O, Staeheli P, Kochs G, (2009) Protective role of interferon-induced Mx GTPases against influenza viruses. Rev Sci Tech 28: 219-231.
23. Salomon R, Staeheli P, Kochs G, Yen HL, Franks J, et al. (2007) Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle 6: 2417-2421.
24. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, et al. (2007) The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81: 10818-10821.
25. Grimm D, Staeheli P, Hufbauer M, Koerner I, Martinez-Sobrido L, et al. (2007) Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A 104: 6806-6811.
26. Dittmann J, Stertz S, Grimm D, Steel J, Garcia-Sastre A, et al. (2008) Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol 82: 3624-3631.
27. Blazejewska P, Koscinski L, Viegas N, Anhlan D, Ludwig S, et al. (2011) Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology 412: 36-45.
28. Zimmermann P, Manz B, Haller O, Schwemmle M, Kochs G, (2011) The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol 85: 8133-8140.
29. Reeves RH, O'Hara BF, Pavan WJ, Gearhart JD, Haller O, (1988) Genetic mapping of the Mx influenza virus resistance gene within the region of mouse chromosome 16 that is homologous to human chromosome 21. J Virol 62: 4372-4375.
30. Malo D, Skamene E, (1994) Genetic-Control of Host-Resistance to Infection. Trends in Genetics 10: 365-371.
31. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, et al. (2009) Host genetic background strongly influences the response to influenza a virus infections. PLoS One 4: e4857.
32. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, et al. (2009) Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83: 10417-10426.
33. Trammell RA, Liberati TA, Toth LA, (2011) Host genetic background and the innate inflammatory response of lung to influenza virus. Microbes Infect.
34. Toth LA, Williams RW, (1999) A quantitative genetic analysis of slow-wave sleep in influenza-infected CXB recombinant inbred mice. Behav Genet 29: 339-348.
35. Ding M, Lu L, Toth LA, (2008) Gene expression in lung and basal forebrain during influenza infection in mice. Genes Brain Behav 7: 173-183.
36. Alberts R, Srivastava B, Wu H, Viegas N, Geffers R, et al. (2010) Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. Microbes Infect 12: 309-318.
37. Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, et al. (2011) The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J Virol.
38. Boon AC, deBeauchamp J, Krauss S, Rubrum A, Webb AD, et al. (2010) Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol 84: 7662-7667.
39. Boon AC, Finkelstein D, Zheng M, Liao G, Allard J, et al. (2011) H5N1 Influenza Virus Pathogenesis in Genetically Diverse Mice Is Mediated at the Level of Viral Load. MBio 2.
40. Burton PR, Tobin MD, Hopper JL, (2005) Key concepts in genetic epidemiology. Lancet 366: 941-951.
41. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA, (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197: 18-24.
42. Gottfredsson M, Halldorsson BV, Jonsson S, Kristjansson M, Kristjansson K, et al. (2008) Lessons from the past: familial aggregation analysis of fatal pandemic influenza (Spanish flu) in Iceland in 1918. Proc Natl Acad Sci U S A 105: 1303-1308.
43. Dowell SF, Bresee JS, (2008) Pandemic lessons from Iceland. Proc Natl Acad Sci U S A 105: 1109-1110.
44. Armstrong DB, (1919) Influenza Observations in Framingham, Massachusetts. Am J Public Health (N Y) 9: 960-965.
45. Isaacs A, Edney M, Donnelley M, Ingram MW, (1950) Influenza in an isolated community. An epidemic on Ocean Island. Lancet 1: 64-66.
46. La Ruche G, Tarantola A, Barboza P, Vaillant L, Gueguen J, et al. (2009) The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill 14.
47. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, et al. (2010) Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 182: 257-264.
48. Thompson DL, Jungk J, Hancock E, Smelser C, Landen M, et al. (2011) Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health 101: 1776-1784.
49. Centers for Disease Control and Prevention (2009) Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives-12 states, 2009. MMWR Morb Mortal Wkly Rep 58: 1341-1344.
50. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8: e1001053.
51. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 5: e13211.
52. Olsen SJ, Ungchusak K, Sovann L, Uyeki TM, Dowell SF, et al. (2005) Family clustering of avian influenza A (H5N1). Emerg Infect Dis 11: 1799-1801.
53. Pitzer VE, Olsen SJ, Bergstrom CT, Dowell SF, Lipsitch M, (2007) Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis 13: 1074-1076.
54. Wang GF, Li W, Li K, (2010) Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol 23: 305-311.
55. Hidaka F, Matsuo S, Muta T, Takeshige K, Mizukami T, et al. (2006) A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol 119: 188-194.
56. Gonzalez BE, Brust DG, (2009) Novel influenza A (H1N1) presenting as an acute febrile encephalopathy in a mother and daughter. Clin Infect Dis 49: 1966-1967.
57. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, et al. (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352: 686-691.
58. Mizuguchi M, Abe J, Mikkaichi K, Noma S, Yoshida K, et al. (1995) Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 58: 555-561.
59. Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, et al. (2009) Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet 84: 44-51.
60. Gika AD, Rich P, Gupta S, Neilson DE, Clarke A, (2009) Recurrent acute necrotizing encephalopathy following influenza A in a genetically predisposed family. Dev Med Child Neurol 52: 99-102.
61. Haralambous E, Weiss HA, Radalowicz A, Hibberd ML, Booy R, et al. (2003) Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol Infect 130: 413-418.
62. McDonald JC, Zuckerman AJ, (1962) ABO Blood Groups and Acute Respiratory Virus Disease. Br Med J 2: 89-90.
63. Frolov VK, Sokhin AA, Sotnik AY, Frolov AK, Lebedinsky AP, et al. (1975) Polymorphism of human blood groups and incidence of influenza A/Hong Kong (H3N2). Acta Virol 19: 406-412.
64. Lebiush M, Rannon L, Kark JD, (1981) The relationship between epidemic influenza A(H1N1) and ABO blood group. J Hyg (Lond) 87: 139-146.
65. Tyrrell DA, Sparrow P, Beare AS, (1968) Relation between blood groups and resistance to infection with influenza and spome picornaviruses. Nature 220: 819-820.
66. Potter CW, Schild GC, (1967) The incidence of HI antibody to Influenza virus A2/Singapore/1/57 in individuals of blood groups A and O. J Immunol 98: 1320-1325.
67. Mackenzie JS, Fimmel PJ, (1978) The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines. J Hyg (Lond) 80: 21-30.
68. Cuadrado RR, Davenport FM, (1970) Antibodies of influenza viruses in military recruits from Argentina, Brazil and Colombia. Their relation to ABO blood group distribution. Bull World Health Organ 42: 873-884.
69. Evans AS, Shepard DA, Richards VA, (1972) ABO blood groups and viral diseases. Yale J Biol Med 45: 81-92.
70. Potter CW, (1969) HI antibody to various influenza viruses and adenoviruses in individuals of blood groups A and O. J Hyg (Lond) 67: 67-74.
71. Aho K, Pyhala R, Visakorpi R, (1980) ABO associated genetic determinant in H1N1 influenza. Tissue Antigens 16: 310-313.
72. Watkin IJ, Tills D, Heath RB, (1975) Studies of the genetic susceptibility of individuals to infection with influenza viruses. Humangenetik 30: 75-79.
73. Tyrrell DA, Peto M, King N, (1967) Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) 65: 327-341.
74. Mackenzie JS, Wetherall JD, Fimmel PJ, Hawkins BR, Dawkins RL, (1977) Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigens. Dev Biol Stand 39: 355-362.
75. Raza MW, Blackwell CC, Molyneaux P, James VS, Ogilvie MM, et al. (1991) Association between secretor status and respiratory viral illness. BMJ 303: 815-818.
76. McMichael AJ, Ting A, Zweerink HJ, Askonas BA, (1977) HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature 270: 524-526.
77. McMichael A, (1978) HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2. J Exp Med 148: 1458-1467.
78. Shaw S, Biddison WE, (1979) HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus. J Exp Med 149: 565-575.
79. Biddison WE, Shaw S, (1979) Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells. J Immunol 122: 1705-1709.
80. Shaw S, Shearer GM, Biddison WE, (1980) Human cytotoxic T-cell responses to type A and type B influenza viruses can be restricted by different HLA antigens. Implications for HLA polymorphism and genetic regulation. J Exp Med 151: 235-245.
81. Doherty PC, Biddison WE, Bennink JR, Knowles BB, (1978) Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med 148: 534-543.
82. Blackwell JM, Jamieson SE, Burgner D, (2009) HLA and infectious diseases. Clin Microbiol Rev 22 370-385, Table of Contents.
83. Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, et al. (2002) The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and-B phenotype. J Virol 76: 582-590.
84. Belz GT, Stevenson PG, Doherty PC, (2000) Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol 165: 2404-2409.
85. Day EB, Charlton KL, La Gruta NL, Doherty PC, Turner SJ, (2011) Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function. J Immunol 186: 6319-6328.
86. Wu C, Zanker D, Valkenburg S, Tan B, Kedzierska K, et al. (2011) Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals. Proc Natl Acad Sci U S A 108: 9178-9183.
87. Hertz T, Nolan D, James I, John M, Gaudieri S, et al. (2011) Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol 85: 1310-1321.
88. Zuniga J, Buendia I, Zhao Y, Jimenez L, Torres D, et al. (2011) Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J.
89. Trammell RA, Toth LA, (2008) Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev Mol Diagn 8: 515-529.
90. Kash JC, Basler CF, Garcia-Sastre A, Carter V, Billharz R, et al. (2004) Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 78: 9499-9511.
91. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
92. Hayashi S, Jibiki I, Asai Y, Gon Y, Kobayashi T, et al. (2008) Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activated protein kinase and c-Jun-N-terminal kinase. Respirology 13: 203-214.
93. Mubareka S, Palese P, (2008) Human genes and influenza. J Infect Dis 197: 1-3.
94. Horisberger MA, (1995) Interferons, Mx genes, and resistance to influenza virus. Am J Respir Crit Care Med 152: S67-71.
95. Calafell i Majo F, Gonzalez Candelas F, (2011) Genetic factors in severe cases of (H1N1) 2009 influenza. Rev Esp Salud Publica 85: 33-36.
96. The Wellcome Trust Case Control Consortium, (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
97. Cirulli ET, Goldstein DB, (2010) Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11: 415-425.
98. Ng SB, Nickerson DA, Bamshad MJ, Shendure J, (2010) Massively parallel sequencing and rare disease. Hum Mol Genet 19: R119-124.